Literature DB >> 12388895

Cognitive behavioural therapy in pain management for sickle cell disease.

V Thomas1.   

Abstract

It is well established that the treatment of pain is improved by the incorporation of psychological, social and behavioural components in that treatment (Rosenthiel and Keefe), 1983). However, until very recently, the management of sickle cell disease (SCD) in British hospitals has focused exclusively on the physical dimension of pain (Thomas et al, 1998). Although pain is wrong (vaso-occlusive crisis), every individual reacts in a different way. This reaction is influenced in part by immediate role models, usually within the family, and by a person's cognition (thought patterns, beliefs and expectations) in relation to the pain. This paper presents research that has shown that cognitive behavioural therapy (CBT) in SCD is an effective aid in the treatment of chronic pain, reducing psychological distress and boosting confidence.

Entities:  

Mesh:

Year:  2000        PMID: 12388895     DOI: 10.12968/ijpn.2000.6.9.9055

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  5 in total

Review 1.  Management of pain in sickle-cell disease.

Authors:  Iheanyi Okpala; Adel Tawil
Journal:  J R Soc Med       Date:  2002-09       Impact factor: 5.344

2.  Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future.

Authors:  William T Zempsky
Journal:  Clin Pediatr Emerg Med       Date:  2010-12-01

Review 3.  Psychological therapies for sickle cell disease and pain.

Authors:  Kofi A Anie; John Green
Journal:  Cochrane Database Syst Rev       Date:  2015-05-08

4.  Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research.

Authors:  Marsha J Treadwell; Kathryn Hassell; Roger Levine; San Keller
Journal:  Clin J Pain       Date:  2014-10       Impact factor: 3.442

Review 5.  Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.

Authors:  Monika R Asnani; Kim R Quimby; Nadia R Bennett; Damian K Francis
Journal:  Cochrane Database Syst Rev       Date:  2016-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.